FP 1096
Alternative Names: Endometriosis treatment - FemmePharma; FP1096; PARDEL™ endometriosis treatment - FemmePharmaLatest Information Update: 23 Nov 2020
At a glance
- Originator FemmePharma; KV Pharmaceutical Company
- Developer FemmePharma
- Class Hormones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Endometriosis
Most Recent Events
- 16 Nov 2020 AMAG Pharmaceuticals has been acquired by Covis Pharma
- 12 Jun 2014 Discontinued - Phase-III for Endometriosis in USA (Vaginal)
- 29 May 2014 KV Pharmaceutical is now called Lumara Health